Source disclosure: February 17, 2026
TECHMATRIX CORPORATION [3762.T]
TOKYO, Feb 17 (Pulse News Wire) – TechMatrix Corporation (3762.T) and its subsidiary PSP Co., Ltd. signed a basic agreement to acquire MedDomain Inc., aiming to integrate advanced digital pathology technologies.
Under the deal, TechMatrix and PSP plan to purchase shares worth approximately ¥2.300 billion to hold more than half of MedDomain's voting rights. The acquisition follows their initial capital and business alliance established on July 26, 2022, aimed at accelerating digital pathology advancements.
TechMatrix sees this move as strategic alignment with its mid-term business plan focusing on expanding its operational scope, overseas markets, and data-driven business creation. The integration of MedDomain’s AI technology with PSP’s cloud-based systems is expected to enhance the development of a comprehensive digital pathology diagnostic platform.
Key stakeholders will be updated on further developments related to the transaction, which is scheduled to conclude by the end of April 2026.
AI-translated content. 🔴 Confidence: Review recommended See terms • Original filing